RecruitingNCT06906744

Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording


Sponsor

University Hospital, Strasbourg, France

Enrollment

500 participants

Start Date

Feb 22, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

Signal loss in cardiotocography (CTG) recordings is numerous and frequent, whether due to artifacts in signal acquisition or confusion over inadvertent maternal heart rate recording, with various negative consequences for neonatal morbidity and unnecessary obstetric interventions. Data on this issue are 10 to 15 years old. CTG remains the primary method for assessing fetal well-being during labor, almost systematically.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Inclusion Criteria4

  • Adult female (≥ 18 years old)
  • Patient treated at a hospital between February 1, 2024 and February 28, 2024
  • Having undergone cardiotocography in the labor and delivery room
  • Gestational age at delivery >36 weeks

Exclusion Criteria3

  • Patient who has expressed opposition to the use of medical record data
  • Patient without CTG
  • Gestational age at delivery <36 weeks

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Service de Gynécologie-Obstétrique CMCO - CHU de Strasbourg - France

Strasbourg, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06906744